Preoperative T Staging of Advanced Gastric Cancer using Double Contrast-Enhanced Ultrasound

Ultraschall in der Medizin

Volumn 33, Issue 7, 2012, Pages

  Li, S ^a   Huang, P ^b   Wang, Z ^c   Chen, J ^d   Xu, H ^a   Wang, L ^c   Zhang, Y ^b   Mo, G ^b   Zhu, J ^b   Cosgrove, D ^e  

^a ZHEJIANG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

CEUS; stomach; tumor staging; ultrasound

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADENOCARCINOMA; AGED; ARTICLE; BIOPSY; CANCER STAGING; ECHOGRAPHY; FEMALE; GASTROSCOPY; HUMAN; IMAGE ENHANCEMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MICROBUBBLE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); ORAL DRUG ADMINISTRATION; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STOMACH; STOMACH TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADMINISTRATION, ORAL; AGED; BIOPSY; CONTRAST MEDIA; FEMALE; GASTROSCOPY; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MALE; MICROBUBBLES; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY; STOMACH; STOMACH NEOPLASMS; SULFUR HEXAFLUORIDE;

EID: 84871646156     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0032-1312958     Document Type: Article

References (33)

1. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1991. CA Cancer J Clin: 1991; 41 19 36
2. Sun X. D., Mu R., Zhou Y. S. et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhong Liu Za Zhi: 2004; 26 4 9
3. Tenderenda M., Rutkowski P., Jesionek-Kupnicka D. et al. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res: 2001; 7 129 134 (Pubitemid 32729764)
4. Kumano S., Murakami T., Kim T. et al. T staging of gastric cancer: role of multi-detector row CT. Radiology: 2005; 237 961 966 (Pubitemid 41636387)
5. Lee M. H., Choi D., Park M. J. et al. Gastric cancer: Imaging and staging with MDCT based on the 7th AJCC guidelines. Abdom Imaging: 2011; 10.1007/s00261-011-9780-3
6. Brenner D. J., Doll R., Goodhead D. T. et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA: 2003; 100 13761 13766 (Pubitemid 37499140)
7. Mocellin S., Marchet A., Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc: 2011; 73 1122 1134
8. Bösing N., Schumacher B., Frieling T. et al. Endoscopic ultrasound in routine clinical practice for staging adenocarcinomas of the stomach and distal esophagus. Chirurg: 2003; 74 214 221; discussion 222-223 (Pubitemid 38264811)
9. Jenssen C., Dietrich C. F., Burmester E. Malignant neoplasias of the gastrointestinal tract - endosonographic staging revisited. Z Gastroenterol: 2011; 49 357 368
10. Nuernberg D., Ignee A., Dietrich C. F. Current status of ultrasound in gastroenterology - bowel and upper gastrointestinal tract - part 1. Z Gastroenterol: 2007; 45 629 640 (Pubitemid 47227234)
11. Iordache S., Saftoiu A., Georgescu C. V. et al. Vascular endothelial growth factor expression and microvessel density - two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointestin Liver Dis: 2010; 19 135 139
12. Laitakari J., Näyhä V., Stenbäck F. Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol: 2004; 57 394 401 (Pubitemid 38446258)
13. Lassau N., Lamuraglia M., Leclère J. et al. Functional and early evaluation of treatments in oncology: interest of ultrasonographic contrast agents. J Radiol: 2004; 85 704 712 (Pubitemid 38886161)
14. Shiyan L., Pintong H., Zongmin W. et al. The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography. Ultrasound Med Biol: 2009; 35 1086 1091
15. Phillips P., Gardner E. Contrast-agent detection and quantification. Eur Radiol: 2004; 14 P4 P10 (Pubitemid 40425141)
16. Lutz H., Bauer U., Stolte M. Ultrasound diagnosis of the stomach wall - experimental studies. Ultraschall in Med: 1986; 7 255 258
17. Akahoshi K., Misawa T., Fujishima H. et al. Preoperative evaluation of gastric cancer by endoscopic ultrasound. Gut: 1991; 32 479 482
18. Kim I. Y., Kim S. W., Shin H. C. et al. MRI of gastric carcinoma: results of T and N-staging in an in vitro study. World J Gastroenterol: 2009; 15 3992 3998
19. Sobin L. H., Wittekind C. TNM classification of malignant tumours (UICC International Union Against Cancer). 6th ed New York Wiley-Liss: 2002
20. Japanese Research Society for Gastric Cancer The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer. Jpn J Surg: 1981; 11 140 145
21. Landis J. R., Koch G. G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics: 1977; 33 363 374 (Pubitemid 8131514)
22. Worlicek H. Sonographic diagnosis of the fluid-filled stomach. Ultraschall in Med: 1986; 7 259 263
23. Piscaglia F., Nolsoe C., Dietrich C. F. et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications. Ultraschall in Med: 2011; DOI 10.1055/s-0031-1281676
24. Abbas S. M., Booth M. W. Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer. Langenbecks Arch Surg: 2005; 390 294 299 (Pubitemid 41110972)
25. Botet J. F., Lightdale C. J., Zauber A. G. et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology: 1991; 181 426 432
26. Segura J. M., Olveira A., Conde P. et al. Hydrogastric sonography in the preoperative staging of gastric cancer. J Clin Ultrasound: 1999; 27 499 504 (Pubitemid 29519437)
27. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med: 1971; 285 1182 1186
28. Zheng Z., Yu Y., Lu M. et al. Double contrast-enhanced ultrasonography for the preoperative evaluation of gastric cancer: a comparison to endoscopic ultrasonography with respect to histopathology. Am J Surg: 2011; 202 605 611
29. Hwang S. W., Lee D. H., Lee S. H. et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol: 2010; 25 512 518
30. Setälä L. P., Kosma V. M., Marin S. et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer: 1996; 74 766 772 (Pubitemid 26300769)
31. Ludeman L., Shepherd N. A. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology: 2005; 47 123 131 (Pubitemid 41113114)
32. Takiguchi N., Nunomura M., Koda K. et al. Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion. Oncol Rep: 2003; 10 433 438
33. Sobin L., Gospodarowicz M., Wittekind C. TNM classification of malignant tumours (UICC International Union Against Cancer). 7th ed New York Wiley-Blackwell: 2009